Innovation Pharmaceuticals Inc (IPIX)

[PlentyParanoid]

Helluva good questions Karin!

We know that FDA and NIH are putting renewed pressure on companies to publish trial results, but what can they do if a co keeps a trial in not completed state for years. Probably nothing.

As to competitive advantage: not updating early stage clinical failure might keep competition chasing possibly wrong target or formulation a bit longer. Much harder to see what benefits there would be for not announcing success.